Virtual Medicinal Product (VMP) - Cabergoline 2mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Cabergoline 2mg tablets Start Date 30-10-2002 End Date
Previous Name Previous Name Cabergoline 2mg tablets Start Date 29-10-2002 End Date 29-10-2002

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Name Basis
rINN - Recommended International Non-proprietary

Codes

ATC Code
N04BC06
BNF Start Date End Date
Current BNF 04090100 Start Date 04-04-2022 End Date
Previous BNF 04090100 Start Date 23-02-2005 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
41872311000001108 26-05-2023
323193003 29-10-2002 25-05-2023

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Cabergoline Based on Ingredient Substance 2 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
20 tablet 8500 Part VIIIA Category C
30 tablet
60 tablet